Crinetics Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
CRNX Nasdaq 2834 www.crinetics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals Announces November 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Nov 10th, 2025 2:28 pm
Crinetics Pharmaceuticals (CRNX): Valuation in Focus After FDA Approval and Positive PALSONIFY Launch Momentum - Nov 9th, 2025 4:11 pm
Why Crinetics Pharmaceuticals Stock Was Sliding on Friday - Nov 7th, 2025 2:16 pm
Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q3 Loss, Lags Revenue Estimates - Nov 6th, 2025 3:20 pm
Crinetics Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update - Nov 6th, 2025 2:05 pm
Crinetics to Highlight Neuroendocrine Tumor Research Progress at the 2025 North American Neuroendocrine Tumor Society Annual Meeting - Oct 23rd, 2025 6:00 am
Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Oct 10th, 2025 2:41 pm
Cantor Fitzgerald Maintains a Buy Rating on Crinetics Pharmaceuticals (CRNX) - Oct 7th, 2025 11:04 am
A Look at Crinetics Pharmaceuticals's Valuation Following FDA Approval of PALSONIFY for Acromegaly - Oct 7th, 2025 8:26 am
Crinetics Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025 - Oct 6th, 2025 2:05 pm
JMP Backs Crinetics Pharmaceuticals, Inc. (CRNX) With Big Upside Post-Approval - Sep 30th, 2025 9:49 am
JPMorgan Lifts PT on Crinetics Pharmaceuticals (CRNX) to $52 From $53, Keeps an Overweight Rating - Sep 30th, 2025 2:01 am
Crinetics Pharma (CRNX) Flies 35% Higher on FDA Approval of Acromegaly Drug - Sep 29th, 2025 4:54 pm
Is Crinetics Pharmaceuticals Stock a Buy? - Sep 28th, 2025 6:30 am
Crinetics Pharma Surges After FDA OKs Its Treatment For Growth Disorder - Sep 26th, 2025 2:22 pm
Sector Update: Health Care Stocks Gain Late Afternoon - Sep 26th, 2025 1:47 pm
FDA Approves Crinetics Pharma's First Daily Pill For Rare Growth Disorder - Sep 26th, 2025 11:07 am
Crinetics Pharmaceuticals Receives FDA Approval for Palsonify to Treat Acromegaly - Sep 25th, 2025 3:55 pm
Crinetics Announces FDA Approval of PALSONIFY™ (paltusotine) for the Treatment of Adults with Acromegaly - Sep 25th, 2025 3:30 pm
Those who invested in Crinetics Pharmaceuticals (NASDAQ:CRNX) five years ago are up 151% - Sep 18th, 2025 6:18 am